| Cat. No. | Product name | CAS No. |
| DC21937 |
Pecavaptan
Featured
Pecavaptan is a vasopressin receptor antagonist. |
1914998-56-3 |
| DC7800 |
RGW 611
Featured
. For the detailed information of RGW 611, the solubility of RGW 611 in water, the solubility of RGW 611 in DMSO, the solubility of RGW 611 in PBS buffer, the animal experiment (test) of RGW 611, the cell expriment (test) of RGW 611, the in vivo, in vitro and clinical trial test of RGW 611, the EC50, IC50,and affinity,of RGW 611, Please contact DC Chemicals.. |
6497-78-5 |
| DCY-078 |
Procyanidin B1
>95% |
20315-25-7 |
| DCY-079 |
Procyanidin B2
>95% |
29106-49-8 |
| DCE-004 |
Dihydrotanshinone I
>98%,Standard References |
87205-99-0 |
| DCW-011 |
Evocarpine
>98%,Standard References |
15266-38-3 |
| DC22287 |
Atractylenolide I
Featured
Atractylenolide I is a sesquiterpene derived from the rhizome of Atractylodes macrocephala, possesses diverse bioactivities, such as neuroprotective, anti-allergic, anti-inflammatory and anticancer properties. Atractylenolide I reduces protein levels of phosphorylated JAK2 and STAT3 in A375 cells, and acts as a TLR4-antagonizing agent. |
73069-13-3 |
| DC23034 |
Isochlorogenic acid C
Featured
4,5-Dicaffeoylquinic acid ( Isochlorogenic acid C) possesses potent hepatoprotective and anti-HBV effects.IC50 value:Target: Anti-hepatitis natural produce.In vitro: To study anti-hepatitis effect of isochlorogenic acid C, anti-apoptotic and anti-injury properties of test compound were evaluated. The results showed that test compound at concentrations of 10 to 100 μg/ml significantly reduced the caspase-3 and transformed growth factor β1 (TGFβ1) levels of the D-GalN-challenged hepatocytes. Also, test compound improved markedly cell viability of the D-GalN-injured hepatocytes and produced a maximum protection rate of 47.28% at a concentration of 100 μg/ml. Furthermore, test compound significantly inhibited productions of HBsAg and HBeAg. Its maximum inhibitory rates on the HBsAg and HBeAg expressions were 86.93 and 59.79%, respectively. In addition, test compound significantly induced the HO-1 expression of HepG2.2.15 cells [1]. In vivo: |
57378-72-0 |
| DCF-029 |
Columbamine
>98%,Standard References |
3621-36-1 |
| DCG-045 |
Nardosinone
>98%,Standard References |
23720-80-1 |
| DCL-036 |
Glucosamine sulfate
>98%,Standard References |
14999-43-0 |
| DCZ-276 |
5-Hydroxy-1-tetralone
>98%,Standard References |
28315-93-7 |
| DCZ-277 |
Methyl 4-hydroxycinnamate
>98%,Standard References |
19367-38-5 |
| DCZ-104 |
4-HYDROXY-3-METHOXYCINNAMALDEHYDE
>98%,Standard References |
458-36-6 |
| DCL-018 |
2-Methoxycinnamic acid
>98%,Standard References |
6099-03-2 |
| DCY-044 |
3-Hydroxy-4-methoxycinnamic acid
>98%,Standard References |
537-73-5 |
| DCJ-059 |
Inosine
>98%,Standard References |
58-63-9 |
| DCH-024 |
cis-Anethol
>98%,Standard References |
104-46-1 |
| DCF-022 |
4-(4-Hydroxyphenyl)-2-butanone
>98%,Standard References |
5471-51-2 |
| DCY-147 |
Isoeugenol
>98%,Standard References |
97-54-1 |
| DCD-064 |
Eugenol
>98%,Standard References |
97-53-0 |
| DCZ-272 |
Isopropyl 4-Hydroxybenzoate
>98%,Standard References |
4191-73-5 |
